
    
      By enrolling patients with unresectable Uterine Cervical Neoplasms adapted to enrolled
      criteria, this study will document for the first time the safety and the short and long term
      efficacy of percutaneous IRE for unresectable Uterine Cervical Neoplasms.
    
  